Definitive Contract 75A50125C00002

Award Date 2/1/25
Potential Completion Date 1/31/28
Potential Value $80M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Swiftwater, PA 18370, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, for the maintenance of an embryonated egg supply to support non-seasonal production of pandemic vaccines. The contract is a cost-plus-fixed-fee arrangement with a potential value of $40,895,013.00. It does not have a set-aside designation. Sanofi Pasteur Inc. is a major pharmaceutical...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Sanofi Pasteur Inc. for the provision of pandemic influenza vaccine. The contract has a firm fixed price of $20,512,982.59 and a performance period ending on September 30, 2009. Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of goods, is the prime contractor and has not been awarded this...
This is a $36,045,700.00 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide vaccines for adults. The contract has an ultimate completion date of June 30, 2016 and was awarded on July 1, 2015. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that provides a range of vaccine products and services to various federal agencies. The contract is not a set-aside award. In addition to this contract, Sanofi...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The contract has a potential value of $339,189.20 and is under a larger Indefinite Delivery Vehicle (IDV) contract named "Pandemic Influenza Preparedness and Response 2016-2021" with a potential value up to $5.87 billion. This contract...
This is a $93,418,143.00 firm fixed price delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Sanofi Pasteur Inc. The purpose is to provide medical countermeasures, such as vaccines and adjuvants, for pandemic preparedness and response as required by HHS. This order is part of a larger $5.87 billion Indefinite Delivery Vehicle (IDV) contract with Sanofi Pasteur to supply...
This federal contract award was made by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, on a firm fixed-price basis. The $56,000.00 purchase order is for the provision of unspecified vaccine products and services, with performance to take place at Sanofi's facility in Swiftwater, Pennsylvania. The contract is not designated as a small business set-aside....
This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to Sanofi Pasteur Inc. for the provision of vaccines. The contract has a ceiling value of $98,094.20 and an ultimate completion date of January 12, 2019. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that holds several indefinite delivery vehicles (IDVs) with federal agencies, including a 5-year, $5.87 billion IDIQ with the HHS Office of the...
This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a global pharmaceutical company, to supply "Dynamic Embryonated Egg Supply" for a total potential value of $38,341,519.50. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and a period of performance through December 2, 2022. Sanofi Pasteur Inc. is the prime contractor and will...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, to acquire medical countermeasures for pandemic influenza preparedness and response. The $1,056,500.00 award is under ASPR's Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery vehicle (IDV), a $5.87 billion IDIQ that enables...
This $2,722,638.00 firm fixed price delivery order was awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The delivery order was placed under the Pandemic Influenza Preparedness and Response 2016-2021 Indefinite Delivery Vehicle, a 5-year contract potentially valued at $5.87 billion. Sanofi Pasteur Inc. will provide vaccine products and services to support public...

This is a $79,838,515.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Sanofi Pasteur Inc. to maintain an embryonated egg supply for non-seasonal production of pandemic vaccines. The contract has an ultimate completion date of January 31, 2028. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, and related services to federal agencies. This award is not associated with a set-aside designation. Sanofi Pasteur Inc. holds several indefinite delivery vehicles (IDVs) with ASPR and other agencies, including a $5.87 billion IDIQ to supply medical countermeasures for emerging health threats and a $634 million Pharmaceuticals and Drugs Federal Supply Schedule contract, leveraging its manufacturing and distribution capabilities to fulfill agency requirements for vaccines and pharmaceuticals supporting public health missions.

Generated 2/13/25, 9:11 AM